Nammi Therapeutics: Funding, Investors & Team (Sep 2026)
Nammi Therapeutics is a company specializing in immunotherapy that creates nano-enhanced chemo-immunotherapy for cancer therapy.
Nammi Therapeutics has raised $1.0M across 1 funding round on record, the most recent a Series B of $1.0M announced in Aug 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nammi Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2024.
Nammi Therapeutics Funding Rounds
Nammi Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Nammi Therapeutics Funding Compared to Other Biotechnology Startups
Nammi Therapeutics' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nammi Therapeutics in Biotechnology and Los Angeles
Companies Similar to Nammi Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Nammi Therapeutics Funding FAQs
What does Nammi Therapeutics do?
Nammi Therapeutics is a company specializing in immunotherapy that creates nano-enhanced chemo-immunotherapy for cancer therapy.
How much funding has Nammi Therapeutics raised?
Nammi Therapeutics has raised $1.0M across 1 round on record. The most recent is a Series B of $1.0M announced in Aug 2024.
When did Nammi Therapeutics last raise funding?
Nammi Therapeutics' most recent funding round on record is a Series B of $1.0M, announced in Aug 2024.
Who founded Nammi Therapeutics?
FundedIQ lists David Stover (Founder) at Nammi Therapeutics.
Where is Nammi Therapeutics headquartered?
Nammi Therapeutics is based in Los Angeles, California, United States.
How many employees does Nammi Therapeutics have?
Nammi Therapeutics is in the 1-10 employee band.
How does Nammi Therapeutics' funding compare to other Biotechnology startups?
Nammi Therapeutics' latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Nammi Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nammi Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.